Mechanisms of Beta 3-adrenoceptor-induced ENOS Activation in Right Atrial and Left Ventricular Human Myocardium

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2004 Oct 7

PMID 15466444

Citations 26

Authors

Klara Brixius

Wilhelm Bloch

Christian Pott

Andreas Napp

Andreas Krahwinkel

Christoph Ziskoven

Marco Koriller

Uwe Mehlhorn

J Hescheler

Bernd Fleischmann

Robert H G Schwinger

Affiliations

Soon will be listed here.

Abstract

beta-Adrenoceptors are important modulators of cardiac function. The present study investigated beta(3)-adrenergic eNOS activation in human myocardium. We measured nitric oxide (NO) liberation (diaminofluorescence) and signal transduction (immunohistochemistry, phosphorylation of eNOS(Ser1177), eNOS(Thr495), eNOS(Ser114), Akt/protein kinase B (Akt/PKB), and eNOS translocation) in human right atrial (RA, aortocoronary-bypass OP) and left ventricular nonfailing (LV, rejected donor hearts) myocardium after application of BRL 37344 (BRL), a preferential beta(3)-adrenoceptor agonist. In both RA and LV, BRL (10 microl) induced a liberation of NO. An eNOS activation via translocation was only observed in RA after application of BRL (10 microM). Yet, the NO liberation in both LV and RA was accompanied by phosphorylation of eNOS(Ser1177) and Akt/PKB. BRL-induced eNOS phosphorylation was abolished by LY292004, a blocker of PI-3 kinase. eNOS-Ser(114) phosphorylation was unchanged in RA, but decreased in LV after beta(3)-adrenergic stimulation. BRL did not alter phosphorylation of eNOS(Thr495). In conclusion, receptor-dependent eNOS activation is differentially regulated in the human heart. In the left ventricle, eNOS activation via phosphorylation seems to be of major importance, whereas in human atrial myocardium eNOS translocation is the predominant mechanism induced by beta(3)-adrenergic activation.

Citing Articles

Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension.

Li B, Zhang Q, Zhang H, Wang C, Xiu R Biosci Rep. 2020; 40(5).

PMID: 32342981 PMC: 7201558. DOI: 10.1042/BSR20200436.

β3 adrenergic receptor antagonist SR59230A exerts beneficial effects on right ventricular performance in monocrotaline-induced pulmonary arterial hypertension.

Sun J, Cheng J, Ding X, Chi J, Yang J, Li W Exp Ther Med. 2019; 19(1):489-498.

PMID: 31853320 PMC: 6909721. DOI: 10.3892/etm.2019.8236.

Cardiac β -adrenoceptors-A role in human pathophysiology?.

Arioglu-Inan E, Kayki-Mutlu G, Michel M Br J Pharmacol. 2019; 176(14):2482-2495.

PMID: 30801686 PMC: 6592859. DOI: 10.1111/bph.14635.

Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.

Wang B, Xu M, Li W, Li X, Zheng Q, Niu X PLoS One. 2017; 12(6):e0179648.

PMID: 28622359 PMC: 5473571. DOI: 10.1371/journal.pone.0179648.

Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.

Cannavo A, Koch W J Cardiovasc Pharmacol. 2017; 69(2):71-78.

PMID: 28170359 PMC: 5295490. DOI: 10.1097/FJC.0000000000000444.

References

Harris M, Ju H, Venema V, Liang H, Zou R, Michell B . Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem. 2001; 276(19):16587-91. DOI: 10.1074/jbc.M100229200. View

Moniotte S, Kobzik L, Feron O, Trochu J, Gauthier C, Balligand J . Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation. 2001; 103(12):1649-55. DOI: 10.1161/01.cir.103.12.1649. View

Bloch W, Mehlhorn U, Krahwinkel A, Reiner M, Dittrich M, Schmidt A . Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide. 2001; 5(4):317-33. DOI: 10.1006/niox.2000.0339. View

Petroff M, Kim S, Pepe S, Dessy C, Marban E, Balligand J . Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol. 2001; 3(10):867-73. DOI: 10.1038/ncb1001-867. View

Reiner M, Bloch W, Addicks K . Functional interaction of caveolin-1 and eNOS in myocardial capillary endothelium revealed by immunoelectron microscopy. J Histochem Cytochem. 2001; 49(12):1605-10. DOI: 10.1177/002215540104901214. View

Bloch W, Addicks K, Hescheler J, Fleischmann B . Nitric oxide synthase expression and function in embryonic and adult cardiomyocytes. Microsc Res Tech. 2001; 55(4):259-69. DOI: 10.1002/jemt.1175. View

Goligorsky M, Li H, Brodsky S, Chen J . Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol Renal Physiol. 2002; 283(1):F1-10. DOI: 10.1152/ajprenal.00377.2001. View

Wu K . Regulation of endothelial nitric oxide synthase activity and gene expression. Ann N Y Acad Sci. 2002; 962:122-30. DOI: 10.1111/j.1749-6632.2002.tb04062.x. View

Kou R, Greif D, Michel T . Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem. 2002; 277(33):29669-73. DOI: 10.1074/jbc.M204519200. View

10.

Fleming I, Busse R . Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2002; 284(1):R1-12. DOI: 10.1152/ajpregu.00323.2002. View

11.

Pott C, Brixius K, Bundkirchen A, Bolck B, Bloch W, Steinritz D . The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium. Br J Pharmacol. 2003; 138(3):521-9. PMC: 1573689. DOI: 10.1038/sj.bjp.0705065. View

12.

Bauer P, Fulton D, Boo Y, Sorescu G, Kemp B, Jo H . Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem. 2003; 278(17):14841-9. DOI: 10.1074/jbc.M211926200. View

13.

Lin M, Fulton D, Babbitt R, Fleming I, Busse R, Pritchard Jr K . Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem. 2003; 278(45):44719-26. DOI: 10.1074/jbc.M302836200. View

14.

Schwinger R, Bohm M, Erdmann E . Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J. 1990; 119(4):899-904. DOI: 10.1016/s0002-8703(05)80329-1. View

15.

Finkel M, Oddis C, Mayer O, HATTLER B, Simmons R . Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther. 1995; 272(2):945-52. View

16.

Kaye D, Wiviott S, Balligand J, Simmons W, Smith T, Kelly R . Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res. 1996; 78(2):217-24. DOI: 10.1161/01.res.78.2.217. View

17.

Fleming I, Bauersachs J, Fisslthaler B, Busse R . Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res. 1998; 82(6):686-95. DOI: 10.1161/01.res.82.6.686. View

18.

Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H . Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998; 70(13):2446-53. DOI: 10.1021/ac9801723. View

19.

Prabhakar P, Thatte H, Goetz R, Cho M, Golan D, Michel T . Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem. 1998; 273(42):27383-8. DOI: 10.1074/jbc.273.42.27383. View

20.

Gauthier C, Leblais V, Kobzik L, Trochu J, Khandoudi N, Bril A . The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 1998; 102(7):1377-84. PMC: 508985. DOI: 10.1172/JCI2191. View